Messoud Ashina
#136,798
Most Influential Person Now
Researcher
Messoud Ashina's AcademicInfluence.com Rankings
Messoud Ashinaphilosophy Degrees
Philosophy
#6950
World Rank
#10082
Historical Rank
Logic
#4031
World Rank
#5273
Historical Rank
Messoud Ashinabiology Degrees
Biology
#9429
World Rank
#12635
Historical Rank
Neuroscience
#1380
World Rank
#1427
Historical Rank
Download Badge
Philosophy Biology
Messoud Ashina's Degrees
- PhD Neuroscience University of Copenhagen
- Doctorate Medicine University of Copenhagen
Why Is Messoud Ashina Influential?
(Suggest an Edit or Addition)Messoud Ashina's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial (2017) (481)
- Origin of pain in migraine: evidence for peripheral sensitisation (2009) (457)
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine (2018) (367)
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura (2010) (343)
- PACAP38 induces migraine-like attacks in patients with migraine without aura. (2009) (334)
- A Systematic Comparison of Motion Artifact Correction Techniques for Functional Near-Infrared Spectroscopy (2012) (312)
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial (2014) (282)
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial (2016) (278)
- Evidence for a vascular factor in migraine (2011) (262)
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention (2019) (250)
- Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study (2013) (240)
- Nitric oxide synthase inhibition in migraine (1997) (239)
- Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine (2008) (228)
- Migraine and structural changes in the brain (2013) (224)
- Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults (2018) (196)
- No increase of calcitonin gene–related peptide in jugular blood during migraine (2005) (193)
- Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. (2014) (181)
- Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial (2019) (179)
- Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks (2000) (176)
- Generalized Hyperalgesia in Patients With Chronic Tension-Type Headache (2006) (175)
- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1) (2020) (168)
- Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial (1999) (168)
- Nitric Oxide Synthase Inhibition: A New Principle in the Treatment of Migraine Attacks (1998) (161)
- Migraine and the trigeminovascular system—40 years and counting (2019) (160)
- Muscle hardness in patients with chronic tension-type headache: relation to actual headache state (1999) (155)
- Nitric oxide-induced headache in patients with chronic tension-type headache. (2000) (154)
- Migraine: epidemiology and systems of care (2021) (149)
- Human models of migraine — short-term pain for long-term gain (2017) (143)
- Calcitonin gene-related peptide and pain: a systematic review (2017) (136)
- Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers (2010) (135)
- Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition (2019) (127)
- Erenumab in chronic migraine with medication overuse (2019) (114)
- Experimental muscle pain and tenderness following infusion of endogenous substances in humans (2003) (111)
- Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers (2012) (108)
- Provocation of migraine with aura using natural trigger factors (2013) (101)
- Plasma levels of calcitonin gene-related peptide in chronic tension-type headache (2000) (101)
- In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache. (2002) (99)
- Neurobiology of Chronic Tension-Type Headache (2004) (98)
- Pathophysiology of tension-type headache (2005) (98)
- Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. (1999) (96)
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study (2018) (96)
- Post-traumatic headache: epidemiology and pathophysiological insights (2019) (95)
- Vasoactive Intestinal Polypeptide Evokes Only a Minimal Headache in Healthy Volunteers (2006) (94)
- Migraine induced by hypoxia: an MRI spectroscopy and angiography study. (2016) (94)
- Tender Points Are Not Sites of Ongoing Inflammation - In Vivo Evidence in Patients with Chronic Tension-Type Headache (2003) (93)
- Diagnosis and management of migraine in ten steps (2021) (92)
- European headache federation consensus on technical investigation for primary headache disorders (2015) (92)
- Increased muscular and cutaneous pain sensitivity in cephalic region in patients with chronic tension‐type headache (2005) (90)
- Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial (2018) (89)
- Migraine. (2020) (89)
- Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura (2017) (87)
- Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans (2013) (86)
- Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial (2021) (85)
- The PACAP receptor: A novel target for migraine treatment (2010) (84)
- Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience (2013) (84)
- Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation (2018) (81)
- Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. (2014) (80)
- Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study (2016) (79)
- Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial (2011) (79)
- Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine (2019) (77)
- Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine (2016) (76)
- Therapeutic novelties in migraine: new drugs, new hope? (2019) (74)
- Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura (2012) (72)
- Change in brain network connectivity during PACAP38-induced migraine attacks (2016) (71)
- Early onset of efficacy with erenumab in patients with episodic and chronic migraine (2018) (70)
- Emerging migraine treatments and drug targets. (2011) (69)
- Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults (2020) (69)
- Sphenopalatine ganglion neuromodulation in migraine: What is the rationale? (2014) (68)
- Randomized, controlled trial of telcagepant over four migraine attacks (2010) (68)
- Migraine: disease characterisation, biomarkers, and precision medicine (2021) (64)
- Calcitonin gene–related peptide does not cause the familial hemiplegic migraine phenotype (2008) (64)
- Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. (2019) (63)
- Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study (2020) (62)
- Migraine: integrated approaches to clinical management and emerging treatments (2021) (62)
- Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs (2010) (60)
- Altered thalamic connectivity during spontaneous attacks of migraine without aura: A resting-state fMRI study (2018) (59)
- Interhemispheric differences of fMRI responses to visual stimuli in patients with side‐fixed migraine aura (2014) (59)
- Serotonergic mechanisms in the migraine brain – a systematic review (2017) (58)
- Prostaglandin E2 (PGE2) Induces Headache in Healthy Subjects (2009) (58)
- Migraine and structural abnormalities in the brain. (2014) (58)
- Migraine and magnetic resonance spectroscopy: a systematic review (2017) (57)
- Familial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric Oxide (2008) (57)
- CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data (2019) (56)
- Morphological Abnormalities of Thalamic Subnuclei in Migraine: A Multicenter MRI Study at 3 Tesla (2015) (55)
- Meningeal contribution to migraine pain: a magnetic resonance angiography study (2019) (54)
- Current understanding of thalamic structure and function in migraine (2018) (53)
- Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial (2019) (53)
- Increased intrinsic brain connectivity between pons and somatosensory cortex during attacks of migraine with aura (2017) (52)
- Migraine (2022) (52)
- Familial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of Migraine (2008) (52)
- Changes in cerebral blood flow after acetazolamide: an experimental study comparing near‐infrared spectroscopy and SPECT (2009) (52)
- Magnetic Resonance Angiography Shows Dilatation of the Middle Cerebral Artery after Infusion of Glyceryl Trinitrate in Healthy Volunteers (2007) (50)
- What have we learnt from triggering migraine? (2010) (49)
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update (2022) (49)
- Experimental Induction of Muscle Tenderness and Headache in Tension-Type Headache Patients (2005) (48)
- Induction of prolonged tenderness in patients with tension‐type headache by means of a new experimental model of myofascial pain (2003) (48)
- Prostaglandins in migraine: update. (2013) (47)
- Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review (2019) (47)
- Prostacyclin (epoprostenol) induces headache in healthy subjects (2008) (47)
- Intact blood−brain barrier during spontaneous attacks of migraine without aura: a 3T DCE‐MRI study (2017) (46)
- Persistent post-traumatic headache attributed to mild traumatic brain injury: Deep phenotyping and treatment patterns (2020) (45)
- Measurement of Muscle Hardness: A Methodological Study (1998) (45)
- Migraine with visual aura associated with thicker visual cortex (2018) (44)
- Cortical abnormalities in episodic migraine: A multi-center 3T MRI study (2018) (44)
- Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients (2017) (42)
- Dual Therapy With Anti‐CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale? (2020) (42)
- Migraine and cluster headache – the common link (2018) (42)
- Possible Mechanisms of Pain Perception in Patients with Episodic Tension-Type Headache. A New Experimental Model of Myofascial Pain (2004) (42)
- Calcitonin Gene‐Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine (2011) (42)
- PACAP27 induces migraine-like attacks in migraine patients (2020) (41)
- Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions (2019) (41)
- A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial (2017) (41)
- A New Technology for Detecting Cerebral Blood Flow: A Comparative Study of Ultrasound Tagged NIRS and 133Xe-SPECT (2012) (41)
- Hemiplegic Migraine Aura Begins With Cerebral Hypoperfusion: Imaging in the Acute Phase (2011) (40)
- Triptans and CGRP blockade – impact on the cranial vasculature (2017) (40)
- Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache (1999) (39)
- No abnormalities of intrinsic brain connectivity in the interictal phase of migraine with aura (2015) (38)
- Prevalence and risk of migraine in patients with rosacea: A population‐based cohort study (2017) (38)
- Calcitonin-gene related peptide and disease activity in cluster headache (2019) (37)
- A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention (2020) (37)
- The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine (2017) (37)
- Sensory migraine aura is not associated with structural grey matter abnormalities (2016) (36)
- The effect of sumatriptan on cephalic arteries - 3T MR-angiography study in healthy volunteers (2013) (34)
- Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine (2018) (34)
- Heterogenous migraine aura symptoms correlate with visual cortex functional magnetic resonance imaging responses (2017) (34)
- Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study (2020) (34)
- Effect of CGRP and sumatriptan on the BOLD response in visual cortex (2012) (33)
- Trigger factors for familial hemiplegic migraine (2011) (32)
- Structural gray matter abnormalities in migraine relate to headache lateralization, but not aura (2015) (32)
- Current and potential future drug therapies for tension-type headache (2003) (32)
- Migraine induction with calcitonin gene-related peptide in patients from erenumab trials (2018) (31)
- Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP (2010) (31)
- Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine (2017) (30)
- Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA (2016) (30)
- The Role of Endothelin in the Pathophysiology of Migraine—a Systematic Review (2018) (30)
- Matrix metalloproteinases during and outside of migraine attacks without aura (2010) (29)
- Calcitonin gene‐related peptide levels during nitric oxide‐induced headache in patients with chronic tension‐type headache (2001) (29)
- Spontaneous low-frequency oscillations in cerebral vessels: applications in carotid artery disease and ischemic stroke. (2010) (29)
- Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study (2020) (29)
- Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial (29)
- Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers (2016) (28)
- Habituation of evoked responses is greater in patients with familial hemiplegic migraine than in controls: a contrast with the common forms of migraine (2011) (28)
- Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients (2021) (28)
- Low 5-HT1B receptor binding in the migraine brain: A PET study (2018) (28)
- Possible Mechanisms of Glyceryl-Trinitrate-Induced Immediate Headache in Patients With Chronic Tension-Type Headache (2000) (27)
- Glyceryl Trinitrate may Trigger Endogenous Nitric Oxide Production in Patients with Chronic Tension-Type Headache (2004) (27)
- Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache (2002) (27)
- Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment (2021) (27)
- Lack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjects (2011) (27)
- Migraine and risk of hemorrhagic stroke: a study based on data from general practice (2014) (27)
- Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura (2010) (26)
- Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2 (PGD2) (2011) (26)
- Challenges in developing drugs for primary headaches (2017) (26)
- Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study (2021) (26)
- Cerebral Asymmetry of fMRI-BOLD Responses to Visual Stimulation (2015) (26)
- Calcitonin gene-related peptide and migraine with aura: A systematic review (2014) (26)
- CGRP in Human Models of Migraine. (2018) (25)
- Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers (2020) (25)
- Coexisting typical migraine in familial hemiplegic migraine (2010) (25)
- Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks (2018) (25)
- Finding New Drug Targets for the Treatment of Migraine Attacks (2009) (24)
- Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine. (2021) (24)
- The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the Prostaglandin E2 human model of headache (2011) (24)
- Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine (2017) (24)
- Levcromakalim, an Adenosine Triphosphate‐Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries (2019) (24)
- A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine (2015) (23)
- Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies (2019) (23)
- Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description (2021) (23)
- Opening of ATP sensitive potassium channels causes migraine attacks with aura. (2021) (22)
- Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs) (2019) (22)
- Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding. (2019) (22)
- High brain serotonin levels in migraine between attacks: A 5-HT4 receptor binding PET study (2018) (22)
- The relationship between migraine and rosacea: Systematic review and meta-analysis (2018) (22)
- Measurement of Blood Flow Velocity in the Middle Cerebral Artery During Spontaneous Migraine Attacks: A Systematic Review (2017) (22)
- CGRP in human models of primary headaches (2018) (21)
- The Cholinomimetic Agent Carbachol Induces Headache in Healthy Subjects (2009) (21)
- Hypersensitivity to Calcitonin Gene–Related Peptide in Post‐Traumatic Headache (2020) (21)
- Vascular changes have a primary role in migraine (2012) (21)
- Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiography (2014) (21)
- Intact neurovascular coupling during executive function in migraine without aura: Interictal near-infrared spectroscopy study (2010) (20)
- Effect of hypoxia on BOLD fMRI response and total cerebral blood flow in migraine with aura patients (2019) (20)
- PACAP38 in human models of primary headaches (2017) (20)
- Evidence of a Christmas spirit network in the brain: functional MRI study (2015) (20)
- Safety and effi cacy of ALD 403 , an antibody to calcitonin gene-related peptide , for the prevention of frequent episodic migraine : a randomised , double-blind , placebo-controlled , exploratory phase 2 trial (2014) (20)
- Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension (2020) (20)
- Spontaneous Low Frequency Oscillations in Acute Ischemic Stroke - A Near Infrared Spectroscopy (NIRS) Study (2014) (19)
- Post-Traumatic Stress Disorder After Traumatic Brain Injury—A Systematic Review and Meta-Analysis (2020) (19)
- Migraine with aura and risk of silent brain infarcts and white matter hyperintensities in women: A population-based MRI-study of Danish twins (2016) (19)
- Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches (2021) (19)
- Hypoxic mechanisms in primary headaches (2017) (18)
- Carbon monoxide may be an important molecule in migraine and other headaches (2014) (18)
- Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine (2021) (18)
- PACAP38: Emerging Drug Target in Migraine and Cluster Headache (2017) (18)
- Can migraine aura be provoked experimentally? A systematic review of potential methods for the provocation of migraine aura (2017) (18)
- Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in man (2011) (18)
- The effect of sodium nitroprusside on cerebral hemodynamics and headache in healthy subjects (2013) (18)
- Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society (2021) (17)
- The L-kynurenine signalling pathway in trigeminal pain processing: A potential therapeutic target in migraine? (2011) (17)
- PACAP38 dose-response pilot study in migraine patients (2017) (16)
- Pharmacological modulation of the bOLD response: A study of acetazolamide and glyceryl trinitrate in humans (2011) (16)
- Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention (2019) (16)
- Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020 (2021) (15)
- Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging (2019) (15)
- Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study (2019) (15)
- Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers (2018) (15)
- Vancouver Declaration on Global Headache Patient Advocacy 2018 (2018) (15)
- Low frequency oscillations in cephalic vessels assessed by near infrared spectroscopy (2012) (15)
- Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study (2021) (14)
- Pathophysiology of migraine and tension-type headache (2012) (14)
- Toward a pragmatic migraine model for drug testing: 1. Cilostazol in healthy volunteers (2016) (14)
- Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects (2019) (14)
- Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers (2020) (14)
- No release of interstitial glutamate in experimental human model of muscle pain (2005) (14)
- Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy (2020) (14)
- Acute headache and persistent headache attributed to cervical artery dissection: Field testing of ICHD-III beta (2014) (14)
- Intravenous Endothelin‐1 Infusion Does Not Induce Aura or Headache in Migraine Patients With Aura (2020) (14)
- Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura (2021) (13)
- The Stereotypical Image of a Person With Migraine According to Mass Media (2020) (13)
- Latest Insights into the Pathophysiology of Migraine: the ATP-Sensitive Potassium Channels (2020) (13)
- Cerebrovascular effects of endothelin-1 investigated using high-resolution magnetic resonance imaging in healthy volunteers (2020) (13)
- Altered Low Frequency Oscillations of Cortical Vessels in Patients with Cerebrovascular Occlusive Disease – A NIRS Study (2013) (13)
- Effect of motion artifacts and their correction on near-infrared spectroscopy oscillation data: a study in healthy subjects and stroke patients (2015) (12)
- Reproducibility of migraine-like attacks induced by phosphodiesterase-3-inhibitor cilostazol (2018) (12)
- Post procedure headache in patients treated for neurovascular arteriovenous malformations and aneurysms using endovascular therapy (2016) (12)
- Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers (2009) (12)
- Sphenopalatine ganglion stimulation induces changes in cardiac autonomic regulation in cluster headache (2018) (12)
- Prevalence of neck pain in migraine: A systematic review and meta-analysis (2022) (12)
- Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study (2020) (12)
- Structural asymmetry of cortical visual areas is related to ocular dominance (2015) (12)
- Low-frequency oscillations and vasoreactivity of cortical vessels in obstructive sleep apnea during wakefulness: a near infrared spectroscopy study. (2013) (11)
- Risk Factors for the Development of Post‐Traumatic Headache Attributed to Traumatic Brain Injury: A Systematic Review (2020) (11)
- Prevalence of right-to-left shunts on transcranial Doppler in chronic migraine and medication-overuse headache (2014) (11)
- Targeting BKCa Channels in Migraine: Rationale and Perspectives (2020) (11)
- Low plasma levels of calcitonin gene-related peptide in persistent post-traumatic headache attributed to mild traumatic brain injury (2020) (11)
- Ictal neck pain investigated in the interictal state – a search for the origin of pain (2019) (11)
- Increased neck muscle stiffness in migraine patients with ictal neck pain: A shear wave elastography study (2020) (11)
- Mechanistic Investigations Support Liver Safety of Ubrogepant (2020) (11)
- Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding (2018) (11)
- Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study (2022) (11)
- Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine (2021) (11)
- Neck pain and headache following whiplash injury: a systematic review and meta-analysis. (2020) (11)
- Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials (2021) (10)
- The Effect of KATP Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers (2021) (10)
- Glutamate levels and perfusion in pons during migraine attacks: A 3T MRI study using proton spectroscopy and arterial spin labeling (2020) (10)
- Effect of the H1-antihistamine clemastine on PACAP38 induced migraine (2018) (10)
- Pathophysiology of tension-type headache: potential drug targets. (2007) (10)
- Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers (2020) (10)
- Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil (2019) (10)
- The vascular effect of glibenclamide: A systematic review (2019) (10)
- Can nitric oxide induce migraine in normal individuals? (2015) (10)
- Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial (2022) (9)
- Ultrasound tagged near infrared spectroscopy does not detect hyperventilation-induced reduction in cerebral blood flow (2016) (9)
- Infusion of pituitary adenylate cyclase-activating polypeptide-38 in patients with rosacea induces flushing and facial edema which can be attenuated by sumatriptan. (2021) (9)
- Effect of KATP channel blocker glibenclamide on levcromakalim-induced headache (2020) (9)
- The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache (2020) (9)
- Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers (2021) (9)
- Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 T (2018) (9)
- Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers (2020) (9)
- Cilostazol induced migraine does not respond to sumatriptan in a double blind trial (2018) (9)
- Migraine without aura is not associated with incomplete circle of Willis: a case–control study using high-resolution magnetic resonance angiography (2014) (8)
- Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies (2022) (8)
- Association of acetazolamide infusion with headache and cranial artery dilation in healthy volunteers (2014) (8)
- Plasma Glucose Levels Increase During Spontaneous Attacks of Migraine With and Without Aura (2020) (8)
- Migraine and light: A narrative review (2022) (8)
- Hypersensitivity to calcitonin gene-related peptide in chronic migraine (2020) (8)
- Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants. (2021) (8)
- CGRP in migraine (2009) (8)
- Carbon monoxide inhalation induces headache in a human headache model (2018) (8)
- Effect of natriuretic peptides on cerebral artery blood flow in healthy volunteers (2015) (8)
- Natriuretic peptides and cerebral hemodynamics (2014) (8)
- Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache (2020) (8)
- Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial (2021) (8)
- Correction to: Therapeutic novelties in migraine: new drugs, new hope? (2019) (7)
- Googling migraine: A study of Google as an information resource of migraine management (2020) (7)
- Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203) (2020) (7)
- Facial pain and multiple cranial palsies in a patient with skin cancer (2011) (7)
- Timing and durability of response to erenumab in patients with chronic migraine (2021) (7)
- Intradural artery dilation during experimentally induced migraine attacks. (2020) (7)
- Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan (2013) (7)
- Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002) (2016) (7)
- Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic (2022) (7)
- Nitric Oxide Modulation of Low‐Frequency Oscillations in Cortical Vessels in FHM – a NIRS Study (2012) (6)
- Headache in Systemic Mastocytosis: A Case Report with Pathophysiological Considerations (2005) (6)
- Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark (2021) (6)
- Symptomatic migraine: A systematic review to establish a clinically important diagnostic entity (2021) (6)
- Brain barriers and their potential role in migraine pathophysiology (2022) (6)
- Migraine with aura in women is not associated with structural thalamic abnormalities (2020) (6)
- Vancouver Declaration II on Global Headache Patient Advocacy 2019 (2018) (6)
- The migraine landscape on YouTube: A review of YouTube as a source of information on migraine (2020) (6)
- Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study (2022) (6)
- High doses of ANP and BNP exacerbate lipolysis in humans and the lipolytic effect of BNP is associated with cardiac triglyceride content in pigs (2019) (6)
- Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults (2019) (5)
- Interictal pontine metabolism in migraine without aura patients: A 3 Tesla proton magnetic resonance spectroscopy study (2021) (5)
- The most important advances in headache research in 2018 (2019) (5)
- Safety and tolerability evaluation of erenumab for the preventive treatment of migraine (2021) (5)
- Effects of glyceryl trinitrate and calcitonin-gene-related peptide on BOLD signal and arterial diameter –methodological studies by fMRI and MRA (2012) (5)
- Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? (2018) (5)
- International Headache Society abstracts (2015) (5)
- The chronobiology of migraine: a systematic review (2021) (5)
- Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review (2022) (5)
- Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura (S32.006) (2018) (4)
- Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study (2019) (4)
- Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2 (2022) (4)
- Calcitonin Gene-Related Peptide in Tension-Type Headache (2002) (4)
- Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study (2021) (4)
- Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention (2022) (4)
- Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study (2022) (4)
- Endovascular thrombectomy and post-procedural headache (2017) (4)
- Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review (2023) (4)
- EHMTI-0165. Acetazolamide infusion induces immediate and delayed headache and intracranial artery dilatation in healthy volunteers (2014) (4)
- Imaging the inflammatory phenotype in migraine (2022) (4)
- Volume of the rectus capitis posterior minor muscle in migraine patients: a cross-sectional structural MRI study (2020) (4)
- Chronic headache and nitric oxide inhibitors (2001) (4)
- Human Cerebral Perfusion, Oxygen Consumption, and Lactate Production in Response to Hypoxic Exposure (2021) (4)
- Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency (2022) (3)
- EHMTI-0186. Multi-center 3T MRI study of cortical thickness abnormalities in migraine (2014) (3)
- Post-traumatic stress disorder attributed to traumatic brain injury in children – a systematic review (2020) (3)
- Sumatriptan Does Not Affect Arteriovenous Oxygen Differences in Jugular and Cubital Veins in Normal Human Subjects (2008) (3)
- Evaluating the Efficacy and Safety of Erenumab (AMG 334) In Chronic Migraine Prevention in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study (S52.002) (2017) (3)
- Updates in the Diagnostic Approach of Headache (2021) (3)
- Subtype-Specific Off-Label Treatment of Rosacea (2021) (3)
- PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine. (2021) (3)
- [Inhibition of nitric oxide synthase has an analgesic effect in chronic pain]. (2000) (3)
- Carbon monoxide inhalation induces headache but no migraine in patients with migraine without aura (2018) (3)
- Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study (2021) (3)
- Calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in migraine treatment (2022) (3)
- PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine (2022) (3)
- Intravascular Endothelin-1 does not trigger or increase susceptibility to Spreading Depolarizations (2020) (2)
- Human models: screening models (2008) (2)
- Debate: Are cluster headache and migraine distinct headache disorders? (2022) (2)
- Migraine trigger factors (2020) (2)
- Pathophysiology of Headaches (2015) (2)
- Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO) (2020) (2)
- Psychiatric Sequelae Following Whiplash Injury: A Systematic Review (2022) (2)
- The effect of sodium nitroprusside on cerebral haemodynamic and headache in healthy subjects (2013) (2)
- Research update for articles published in EJCI in 2012 (2013) (2)
- Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies (2022) (2)
- Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine (2022) (2)
- Pharmacological migraine provocation: a human model of migraine. (2010) (2)
- Vasomotor reactions in the face and head of patients with migraine (2018) (2)
- Reply: Hyperpolarization through ATP-sensitive potassium channels, relevance to migraine pathology. (2020) (2)
- Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies (2023) (2)
- [Clinical symptoms and pathophysiology of migraine]. (2008) (2)
- Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine (2021) (2)
- Low frequency activation of the sphenopalatine ganglion does not induce migraine-like attacks in migraine patients (2020) (2)
- One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey (2022) (2)
- S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation? (2020) (2)
- PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation (2021) (2)
- [Medication overuse headache]. (2006) (2)
- Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial (2023) (1)
- The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology (2022) (1)
- Neurovascular origin of primary headaches (2019) (1)
- Multi-Center 3T MRI Study of Thalamic Morphology in Migraine Using Label-Fusion-Based Segmentation and Deformation Based Morphometric Surface Analysis (S32.003) (2014) (1)
- Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study (2019) (1)
- Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity (2022) (1)
- Long‐term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis (2022) (1)
- Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis (2022) (1)
- CALCITONIN GENE-RELATED PEPTIDE (CGRP) IN CHRONIC TENSION-TYPE HEADACHE (2001) (1)
- Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America (2022) (1)
- Reducing Episodic Cluster Headaches: Focus on Galcanezumab (2020) (1)
- The temporal evolution of a facial pain syndrome associated with neurovascular contact: a case report (2015) (1)
- Calcitonin gene-related peptide — beyond migraine prophylaxis (2019) (1)
- Extracranial source of increased CGRP in migraine children? (2010) (1)
- Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences (2022) (1)
- The changing faces of migraine (2019) (1)
- Extreme ecchymoses in a migraine patient using concomitant treatment with calcitonin gene-related peptide receptor antibodies and fish oil supplements: a case report (2021) (1)
- Vasoactive intestinal polypeptide is unlikely to be a target for headache and migraine treatment (2008) (1)
- Intracranial and extracranial arteries in migraine – Authors' reply (2013) (1)
- Clinical characteristics of combined rosacea and migraine (2022) (1)
- Prolactin in headache and migraine: A systematic review of clinical studies (2023) (1)
- Odds ratios for response to fremanezumab in migraine patients with inadequate response TO 2-4 migraine preventive medication classes: Results of the focus phase 3B study (2019) (0)
- Magnetic Resonance Angiography and Migraine (2012) (0)
- Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005) (2023) (0)
- EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase (2014) (0)
- Correction: Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study (2023) (0)
- Magnetic Resonance Angiography Reveals Intracranial but No Extracranial Arterial Dilatation during Migraine Attacks (2013) (0)
- Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition (2022) (0)
- Cluster headache – The worst possible pain on YouTube (2022) (0)
- EHMTI-0372. No abnormalities of intrinsic brain connectivity during the interictal phase of migraine with aura (2014) (0)
- Reply (2011) (0)
- Corrigendum to: PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation (2022) (0)
- Effect of calcitonin gene-related peptide and sildenafil on intracranial dural arteries : A 3T MR-angiography study in healthy volunteers (2017) (0)
- Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study (P12-12.002) (2023) (0)
- Erenumab (2021) (0)
- Neuropeptides and channels: Data from clinical trials and experimental models (2021) (0)
- [Basic mechanisms of migraine and new methods of treatment]. (2016) (0)
- EHMTI-0079. Reduced volume of anterior thalamic nuclei in migraineurs (2014) (0)
- [Events in the Danish Headache Society in 2012]. (2013) (0)
- Chapter 6 Migraine (2008) (0)
- Greater Occipital Nerve Block with Local Anesthetics and Corticosteroids in Treatment-Resistant Chronic Migraine (2021) (0)
- [A new therapeutic principle for migraine]. (2008) (0)
- Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark (2022) (0)
- Placebo Response in Human Models of Headache (2019) (0)
- Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO) (870) (2020) (0)
- brain systematic review and meta-analysis (2013) (0)
- HeadachesImplications for the Pathophysiology of - Trigeminal Neurons With Meningeal Input in Rat Biphasic Response to Nitric Oxide of Spinal (2015) (0)
- Cranial neuralgias and persistent idiopathic facial pain (2020) (0)
- Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine (2018) (0)
- Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study. (2023) (0)
- Prolactin in headache and migraine: A systematic review of preclinical studies. (2023) (0)
- The KATP channel in migraine pathophysiology (2018) (0)
- Recommendations for the management of headaches during the COVID-19 pandemic (2020) (0)
- Board Walk – April 2021 (2021) (0)
- Calcitonin Gene-Related Peptide in Tension-Type Headache (2001) (0)
- HERALDING A NEW ERA OF EPISODIC, CHRONIC AND REFRACTORY MIGRAINE MANAGEMENT INDEPENDENT MEDICAL EDUCATION SYMPOSIUM SCIENTIFIC SUMMARY HERALDING A NEW ERA OF EPISODIC, CHRONIC AND REFRACTORY MIGRAINE MANAGEMENT (2018) (0)
- Lifelong contribution to headache science: A tribute to Professor Jes Olesen (2017) (0)
- Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study (2023) (0)
- Arterial responses to infusion of glucagon-like peptide-1 in humans: A randomized trial study (2022) (0)
- Board Walk – August 2021 (2021) (0)
- Into the Masseter Muscle Afferent Discharge Evoked by Injection of Glutamate Sex-Related Differences in Human Pain and Rat (2015) (0)
- Board Walk – October 2019 (2019) (0)
- Reduction in migraine days with aura with fremanezumab in patients with documented inadequate response to 2-4 classes of migraine preventive medications in the focus study (2019) (0)
- EHMTI-0393. Abnormal ictal large-scale network connectivity in migraine without aura: a resting-state functional connectivity study (2014) (0)
- How Specific Is the Translational Animal Model of Trigeminal Autonomic Cephalalgias? (2015) (0)
- 1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress. (2021) (0)
- University of Southern Denmark Migraine with aura and risk of silent brain infarcts and white matter hyperintensities (2016) (0)
- Ultra-high field MR angiography in human migraine models (2019) (0)
- How Cluster Headache and Other Trigeminal Autonomic Cephalalgias Present (2011) (0)
- Characterizing healthcare utilization patterns in a Danish population with headache: results from the nationwide headache in Denmark (HINDER) panel (2023) (0)
- Reversion from chronic to episodic migraine and clinically meaningful responses to fremanezumab in patients with inadequate response to 2-4 classes of migraine preventive medications (2019) (0)
- Migraine aura‐like episodes following sclerotherapy for varicose veins of the lower extremities—A systematic review (2023) (0)
- REPRINTED WITH PERMISSION OF IASP – PAIN 161 (2020) 880–888: Neck pain and headache after whiplash injury: a systematic review and meta-analysis (2021) (0)
- CHAPTER 57 – TENSION-TYPE HEADACHE (2007) (0)
- Migraine neurobiology and treatment (2012) (0)
- Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial (2023) (0)
- activityganglion do not control spinal trigeminal Calcitonin gene-related peptide receptors in rat (2015) (0)
- Human Models (2021) (0)
- P.566 Sumatriptan binds to central 5-HT1B receptors in migraine patients (2019) (0)
- Adenosine causes short-lasting vasodilation and headache, but not migraine attacks in migraine patients: A randomized clinical trial. (2022) (0)
- Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures (S47.007) (2023) (0)
- Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial. (2023) (0)
- Ultra-high field MR angiography in human migraine models: a 3.0T/7.0T comparison study (2019) (0)
- Syddansk Universitet Endovascular thrombectomy and post-procedural headache (2017) (0)
- Syddansk Universitet Migraine with aura and risk of silent brain infarcts and white matter hyperintensities (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Messoud Ashina?
Messoud Ashina is affiliated with the following schools:
